SCHEMBL20481990

SCHEMBL20481990

CCOC(=O)c1cc2sc(Br)c(Br)c2s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 2/20 0.47
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
TSHR P16473 2/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPT P10636 6/20 0.42
KDM4E B2RXH2 4/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
JAK2 O60674 1/20 0.42
JAK1 P23458 1/20 0.42
TYK2 P29597 1/20 0.42
JAK3 P52333 1/20 0.42
CASP3 P42574 1/20 0.42
ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL400786 0.85 GPR35 (0.52) PTPN2HDAC3HDAC4HDAC1HDAC6
SCHEMBL17448374 0.83 HDAC3 (0.49) PTPN2HDAC3HDAC4HDAC1HDAC6
SCHEMBL2241077 0.82 TSHR (0.52) PTPN2HDAC3HDAC4HDAC1HDAC6
SCHEMBL6812309 0.80 PTPN2 (0.49) PTPN2HDAC3HDAC4HDAC1HDAC6
SCHEMBL17081033 0.79 TSHR (0.47) PTPN2HDAC3HDAC4HDAC1HDAC6
SCHEMBL10144299 0.77 GAA (0.50) PTPN2HDAC3HDAC4HDAC1HDAC6
SCHEMBL6739730 0.77 PTPN2 (0.46) PTPN2HDAC3HDAC4HDAC1HDAC6
SCHEMBL422589 0.77 POLB (0.57) PTPN2HDAC3HDAC4HDAC1HDAC6
SCHEMBL17447083 0.76 GAA (0.49) PTPN2HDAC3HDAC4HDAC1HDAC6
SCHEMBL13961924 0.75 GPR35 (0.48) PTPN2HDAC3HDAC4HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108503655-B Heterocyclic compound and organic electronic device using same 机光科技股份有限公司 2021-01-08 CN disclosed
US-20180247770-A1 HETEROCYCLIC COMPOUND FOR ORGANIC ELECTRONIC DEVICE AND USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2018-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180247770-A1 HETEROCYCLIC COMPOUND FOR ORGANIC ELECTRONIC DEVICE AND USING THE SAME OR10J3, BMI1, SIK1 PTPN2 3407/4885HDAC3 1638/4885HDAC4 207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.